The angiotensin II type 1 receptor antagonist telmisartan inhibits cell proliferation and tumor growth of esophageal adenocarcinoma via the AMPKα/mTOR pathway<i>in vitro</i>and<i>in vivo</i>
Shintaro Fujihara(Kagawa University), Tsutomu Masaki(Kagawa University)
Cited by 39
Related Papers
Associations between Zinc Deficiency and Metabolic Abnormalities in Patients with Chronic Liver Disease
|Nutrients|2018|174
Molecular and Functional Roles of MicroRNAs in the Progression of Hepatocellular Carcinoma—A Review
|International Journal of Molecular Sciences|2020|125
Effect of the anti-diabetic drug metformin in hepatocellular carcinoma in vitro and in vivo
|International Journal of Oncology|2014|96
Combination therapy of percutaneous ethanol injection and radiofrequency ablation against hepatocellular carcinomas difficult to treat
|International Journal of Oncology|2002|56
Antitumor effect of metformin in esophageal cancer: In vitro study
|International Journal of Oncology|2012|51